Hologic (HOLX) stock fell by 1.61%, likely influenced by broader market trends affecting large-cap medical companies like Bayer and Pfizer, which were compared in terms of revenue, earnings, and overall business performance in the article.

Hologic (HOLX) stock fell by 1

Hologic (HOLX) stock rose by 0.61% after the Teachers Retirement System of Kentucky increased its holdings in the company, alongside notable investments made by other institutional investors, indicating growing confidence in Hologic's potential.

Hologic (HOLX) stock rose by 0

Hologic, Inc. (NASDAQ:HOLX) saw its stock rise by 0.61% due to recent positive earnings results that surpassed analysts' expectations and upgrades from analysts such as Citigroup, which raised its price target significantly.

Hologic, Inc

The article discusses the positive collaboration between finance and marketing at AT&T, highlighting how this partnership drives business growth and financial performance. Hologic (HOLX) stock rose by 0.61% due to investor confidence, likely influenced by favorable developments or outlooks in the healthcare sector, although specific details about Hologic's performance or events were not mentioned in the article.

The article discusses the positive collaboration between finance and marketing at AT&T, highlighting

Hologic (NASDAQ: HOLX) experienced a 0.47% decline in stock price following a significant reduction in its shares held by Signaturefd LLC and various institutional investors adjusting their positions, alongside changing analyst ratings and projections for the company.

Hologic (NASDAQ: HOLX) experienced a 0

Hologic, Inc. (HOLX) stock fell by 0.47% amid mixed institutional trading activity, with some firms reducing their positions in the company, potentially indicating a lack of confidence or strategy shifts among investors.

Hologic (HOLX) stock decreased by 0.05% partly due to Envestnet Asset Management Inc. reducing its stake in the company by nearly 20%, amidst several other hedge funds adjusting their holdings and a general downward trend in price targets from various research firms.

Hologic (HOLX) stock decreased by 0

Hologic (HOLX) stock experienced a slight decline of 0.05% despite an increased price target by Mizuho from $65.00 to $70.00, indicating potential upside, as the overall market sentiment and performance of their recent earnings report showed a slight revenue decrease year-over-year.

Hologic (HOLX) stock experienced a slight decline of 0

The article reports that Hologic (HOLX) stock fell by 2.1% amid broader market declines influenced by disappointing earnings from financial companies and mixed economic signals, which contributed to a cautious investor sentiment.

The article reports that Hologic (HOLX) stock fell by 2

Hologic (HOLX) stock fell by 1.67% following a decline in its share ratings from multiple analysts and changes in some institutional investment positions, including Greenleaf Trust reducing its stake in the company.

Hologic (HOLX) stock fell by 1.67% primarily due to a significant reduction in stake by Nisa Investment Advisors LLC and a mixed sentiment among analysts regarding the company's future performance, as evidenced by downgrades and reduced price targets from several firms.

Hologic (HOLX) stock fell by 1.67% likely due to a combination of decreasing institutional holdings, mixed analyst ratings adjustments, and a slight revenue decline in their most recent quarterly earnings report compared to the previous year.

Hologic (HOLX) stock fell by 1.69% after several research analysts downgraded their price targets for the company, indicating a bearish sentiment among investors despite a slight earnings beat in its last quarterly report.

Hologic, Inc. (HOLX) stock experienced a decline of 1.69% following Bank of New York Mellon Corp's decision to reduce its holdings in the company by 3.5% amidst mixed reactions from analysts regarding the company's financial outlook and target prices.

Hologic (HOLX) stock fell by 0.63% as Wealth Enhancement Advisory Services LLC reduced its stake by 14.5%, reflecting broader institutional trading patterns, which may have contributed to the stock's decline.

Hologic (HOLX) stock fell by 0

The article primarily discusses a bullish investment thesis on Amazon.com, Inc. (AMZN) focusing on its dominance in cloud computing and AI, while noting recent stock depreciation, but it does not provide direct information on Hologic (HOLX) or the reasons for its 0.63% decline. 

The stock price decline for Hologic (HOLX) could be attributed to a variety of market factors or company-specific developments not detailed in the provided excerpt.

The article primarily discusses a bullish investment thesis on Amazon

Hologic, Inc. (HOLX) stock fell by 0.8% following a report indicating that significant institutional investors, including Sumitomo Mitsui Trust Group Inc., reduced their holdings in the company, which raised concerns among investors about potential weakening demand or performance.

Hologic (HOLX) stock declined by 0.8% due to a series of downward adjustments in price targets by multiple equity analysts following a slight revenue dip in its recent earnings report.

Hologic (HOLX) stock declined by 0

Hologic, Inc. (NASDAQ: HOLX) stock experienced a slight decline of 0.05%, attributed primarily to recent downgrades from various brokerages and overall uncertainty in market conditions.

Hologic Inc. (HOLX) stock rose 0.26% likely due to increased institutional investment, with Diversified Trust Co and other hedge funds boosting their positions in the company, suggesting growing confidence in its future earnings prospects.

Hologic Inc

Hologic (NASDAQ: HOLX) stock rose by 1.31% due to the significant uptick in institutional investment, including a new stake from the Kentucky Retirement Systems Insurance Trust Fund and increased holdings from several other hedge funds, reflecting growing confidence in the company's market position.

Hologic (NASDAQ: HOLX) stock rose by 1

Hologic, Inc. (HOLX) stock decreased by 0.86% following reports that PFG Investments LLC reduced its stake in the company by 21.9%, along with several other institutional investors adjusting their holdings amid mixed analysts' ratings and a slight decline in revenue year-over-year.

Hologic (HOLX) stock experienced a decline of 0.86% due to broader market pressures possibly linked to investor sentiment affecting healthcare stocks and competitive comparisons with larger firms like AbbVie that highlight differences in performance metrics and valuations.

Hologic (HOLX) stock experienced a decline of 0

Hologic, Inc. (NASDAQ: HOLX) shares increased by 0.62% following significant investments from various institutional investors during the first quarter, indicating growing confidence in the company amid its consistent earnings performance and strong market presence in women's health products.

Hologic (HOLX) stock experienced a slight decline of 0.08% likely due to significant changes in institutional investor positions, including a 90.7% reduction by Nilsine Partners LLC and downgrades by several research analysts which may indicate concerns about future performance.

Hologic, Inc. (NASDAQ:HOLX) stock decreased by 0.27% amid mixed analyst ratings and reduced price targets from several brokerages, reflecting concerns over its revenue decline and market performance.

Hologic (HOLX) stock increased by 0.66% primarily due to a combination of mixed trading activity among institutional investors, with some increasing their holdings significantly, along with the company's recent earnings performance surpassing analysts' estimates.

Hologic (HOLX) stock increased by 0

Hologic (NASDAQ: HOLX) stock rose by 0.66% due to increased institutional investment, with several hedge funds boosting their stakes in the company during the recent quarters, indicating strong interest from institutional investors.

Hologic (NASDAQ: HOLX) stock rose by 0

Hologic (HOLX) stock rose by 0.37% amid a broader market rally as investors remained optimistic following the commencement of critical US-China trade talks that may influence economic conditions and stock performance.

Hologic, Inc. (NASDAQ:HOLX) experienced a decline of 0.75% in its stock price due to a significant increase in short interest, with 7.26 million shares sold short in May, reflecting a 35.7% rise from April, which indicates growing bearish sentiment among investors.

HOLX

Latest News & Analysis